Marshall Wace’s Gilead Sciences GILD Stock Holding History

Marshall Wace’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100	Closed	-$12.3K	–	3391
2025 Q4	$12.3K	Hold	100	–	–	﹤0.01%	2849
2025 Q3	$11.1K	Buy	+100	New	+$11.4K	﹤0.01%	2801
2023 Q3	–	Sell	-191,200	Closed	-$14.7M	–	2378
2023 Q2	$14.7M	Buy	+191,200	New	+$15.2M	0.03%	591
2023 Q1	–	Sell	-37,400	Closed	-$3.21M	–	2827
2022 Q4	$3.21M	Buy	37,400 +3,000	+9%	+$238K	0.01%	1460
2022 Q3	$2.12M	Buy	+34,400	New	+$2.17M	﹤0.01%	1970
2022 Q1	–	Sell	-59,600	Closed	-$4.33M	–	3577
2021 Q4	$4.33M	Sell	59,600 -45,700	-43%	-$3.15M	0.01%	1472
2021 Q3	$7.36M	Buy	105,300 +88,900	+542%	+$6.25M	0.03%	733
2021 Q2	$1.13M	Buy	+16,400	New	+$1.1M	0.01%	1754

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace's GILD Position: Q2 2026 in Review

Marshall Wace reduced its Gilead Sciences (GILD) stake by 91% in Q2 2026, selling an estimated $277M and leaving 204,677 shares worth $25.9M. The position accounts for 0.02% of the portfolio, ranked #615.

Marshall Wace first reported a position in GILD in Q1 2014 and has held it in 42 quarters since. The position peaked at $421M in Q1 2023. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Marshall Wace held 204,677 shares of Gilead Sciences worth $25.9M as of Q2 2026.
Marshall Wace sold 2,105,838 Gilead Sciences shares in Q2 2026, an estimated $277M.
Gilead Sciences made up 0.02% of Marshall Wace's portfolio in Q2 2026, its #615 holding.
Marshall Wace first reported a position in Gilead Sciences in Q1 2014 and has held it in 42 quarters since.
Marshall Wace's Gilead Sciences position peaked at $421M in Q1 2023.
2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.